2Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J]. Circulation, 2001,103(13) : 1813-1818.
2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segement elevation myocardial infarction. A report of American College of Cardiology/American Heart Association task force or parctice guidelines. J Am Coll Cariol. 2000, 36(3):970.
3Ross R. Atherosclerosis-An inflammatory disease. N Eng1 J Med. 1999, 340:115.
4Biasucci LM, Liuzzo G, Angiolillo DJ, et al. Inflammation and actue coronary syndromes. Heart. 2000, 25(2):108.
5Liuzzo G, Biasucci L M, Gallimore J R, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med, 1994, 331: 417-424.
6Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000, 342: 836-843.
7Kuller L H, Tracy R P, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol, 1996,144: 537-547.
8Iftihar J K, Willian D E, Robert S S. Vulnerable plaque: Pathobiology and clinical implication. Ann Inter Med, 1998, 129:1050-1060.
9Prediman K, Shah M D. Plaque disruption and thrombosis: Potential role of inflammation and infection. Cardiol Rev, 2000, 8: 32-39.
10Haught W H, Mansour M, Rothlein R, et al. Alteration on circulating intercellular adhesion molexule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J, 1996, 132: 1-6.
